ProQR Therapeutics (PRQR) Depreciation & Amortization (CF) (2013 - 2026)
ProQR Therapeutics' Depreciation & Amortization (CF) came in at $821,790 for the quarter ended Jun 30, 2026, up 7.6% from $764,073 a year earlier and up 1.1% from the prior quarter.
ProQR Therapeutics (PRQR) Depreciation & Amortization (CF) (2013 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, ProQR Therapeutics reported Depreciation & Amortization (CF) of $3.21 million, up 8.8% year-over-year; for the year ended Dec 31, 2025, it was $3.05 million, up 2.2% from the prior year.
- Depreciation & Amortization (CF) has increased in each of the last three years, with a five-year compound annual growth rate of 2.6% (years ended Dec 2020 to Dec 2025).
- Going back by year, Depreciation & Amortization (CF) was $2.99 million in the year ended Dec 31, 2024 (+9.9%), $2.72 million in the year ended Dec 31, 2023 (+2.3%), $2.66 million in the year ended Dec 31, 2022 (-3.6%) and $2.76 million in the year ended Dec 31, 2021 (+2.5%).
- The figure for the quarter ended Jun 30, 2026 represents the highest quarterly Depreciation & Amortization (CF) since the quarter ended Jun 30, 2018.
- Year-over-year, Depreciation & Amortization (CF) has increased for four consecutive quarters, with growth averaging 3.7% over the last eight quarters.
- The fastest year-over-year change in Depreciation & Amortization (CF) over five years came in the quarter ended Mar 31, 2024 (growth of 27.4%), and the weakest in the quarter ended Dec 31, 2021 (a decline of 18.8%).
- Business Quant data shows PRQR's Depreciation & Amortization (CF) at $812,497 (quarter ended Mar 31, 2026), $790,386 (quarter ended Dec 31, 2025) and $784,436 (quarter ended Sep 30, 2025) in the three quarters before the quarter ended Jun 30, 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dep. & Amort. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 534.00 Mn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 1.96 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 194.00 Mn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 599.00 Mn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | 1.93 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 1.11 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | 98.00 Mn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 1.62 Bn |
| 10 | ProQR Therapeutics | 171.74 Mn | -291.86 Mn | - | 821,789.83 |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 821,789.83 |
| Mar 31, 2026 | 812,497.48 |
| Dec 31, 2025 | 790,385.55 |
| Sep 30, 2025 | 784,435.97 |
| Jun 30, 2025 | 764,072.79 |
| Mar 31, 2025 | 713,177.65 |
| Dec 31, 2024 | 717,027.51 |
| Sep 30, 2024 | 755,575.02 |
| Jun 30, 2024 | 765,667.07 |
| Mar 31, 2024 | 750,675.98 |
| Dec 31, 2023 | 783,284.25 |
| Sep 30, 2023 | 698,875.09 |
| Jun 30, 2023 | 646,821.09 |
| Mar 31, 2023 | 589,264.66 |
| Dec 31, 2022 | 763,145.03 |
| Sep 30, 2022 | 617,063.89 |
| Jun 30, 2022 | 630,630.50 |
| Mar 31, 2022 | 639,732.50 |
| Dec 31, 2021 | 631,471.97 |
| Sep 30, 2021 | 641,532.30 |
ProQR Therapeutics Depreciation & Amortization (CF) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=PRQR&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "depreciation-and-amortization-cf", "ticker": "PRQR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=PRQR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();